<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Intensive Care Med Exp</journal-id><journal-id journal-id-type="iso-abbrev">Intensive Care Med Exp</journal-id><journal-title-group><journal-title>Intensive Care Medicine Experimental</journal-title></journal-title-group><issn pub-type="epub">2197-425X</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4797785</article-id><article-id pub-id-type="publisher-id">112</article-id><article-id pub-id-type="doi">10.1186/2197-425X-2-S1-P55</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>0733. Impact of endotoxin challenge on disseminated intravascular coagulation in obese minipigs</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Duburcq</surname><given-names>T</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Tournoys</surname><given-names>A</given-names></name><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Pattou</surname><given-names>F</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Hubert</surname><given-names>T</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Gmyr</surname><given-names>V</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Quintane</surname><given-names>L</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Favory</surname><given-names>R</given-names></name><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Mangalaboyi</surname><given-names>J</given-names></name><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Jourdain</surname><given-names>M</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff3"/></contrib><aff id="Aff1"><label/>INSERM, U859 Lille, France </aff><aff id="Aff2"><label/>European Genomic Institute for Diabetes (EGID), Lille, France </aff><aff id="Aff3"><label/>Pole de R&#x000e9;animation CHRU, Lille, France </aff><aff id="Aff4"><label/>Centre de Biologie Pathologie CHRU, Lille, France </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>9</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>9</month><year>2014</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2014</year></pub-date><volume>2</volume><issue>Suppl 1</issue><elocation-id>P55</elocation-id><permissions><copyright-statement>&#x000a9; Duburcq et al; licensee Springer. 2014</copyright-statement><license license-type="open-access"><license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><conference><conf-name>ESICM LIVES 2014</conf-name><conf-loc>Barcelona, Spain</conf-loc><conf-date>27 September - 1 October 2014</conf-date><string-conf><uri>http://www.esicm.org</uri></string-conf></conference><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>An early activation of coagulation and fibrinolysis occurs during sepsis and results in a marked increase of thrombin and fibrin formation, leading to the syndrome of disseminated intravascular coagulation (DIC). DIC is a strong predictor of death and multiple organ failure in patients with septic shock [<xref ref-type="bibr" rid="CR1">1</xref>]. Obesity has been demonstrated to be a hypercoagulable [<xref ref-type="bibr" rid="CR2">2</xref>] and hypofibrinolytic [<xref ref-type="bibr" rid="CR3">3</xref>] state but its impact on coagulation and fibrinolysis during sepsis has never been studied.</p></sec><sec id="Sec2"><title>Objectives</title><p>In this study, we aimed to determine if obesity impairs DIC in an acute endotoxic shock using minipigs.</p></sec><sec id="Sec3"><title>Methods</title><p>This was a prospective, comparative and experimental study, approved by the Animal Ethics Committee. Pigs were chosen as a clinically relevant species, resembling to humans in coagulation reactions. Four groups of five &#x0201c;Yucatan&#x0201d; minipigs were studied: lean and obese control groups, lean LPS group receiving Escherichia Coli endotoxin (LPS) and obese LPS group receiving the same endotoxin dose. We measured standard coagulation parameters [prothrombin time (PT), platelet count and fibrinogen levels], thrombin-antithrombin complex (TAT), tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1). All measurements were performed at baseline and at 30, 60, 90, 150 and 300 minutes. Results were given as median with 25-75 interquartile ranges.</p></sec><sec id="Sec4"><title>Results</title><p>At baseline, platelet count (477 [428-532] vs. 381 [307-442] G/l; p=0.005) and fibrinogen levels (4.6 [3.8-5.2] vs. 2 [1.8-2.9] g/l; p&#x0003c; 0.001) were significantly higher whereas prothrombin time (80 [76-92] vs. 96 [89-100] %; p=0.01) was significantly lower in obese pigs compared to lean pigs. Control groups remained stable during the study-period. In LPS groups, administration of endotoxin resulted in a typical hypokinetic shock with DIC. The decrease in coagulation parameters (PT, platelet count and fibrinogen levels) and the increase in TAT complex (581 [382-1057] vs. 247 [125-369] &#x000b5;g/ml at 150 min; p=0.03) were significantly more important in obese LPS group compared to lean LPS group. Concerning the fibrinolytic reaction, we found a more important increase of PAI-1 in obese LPS group at 300 min (481 [365-617] ng/ml vs. 355 [209-660] ng/ml; p=0.66) without reaching statistical significance. Nevertheless, the increase of t-PA was significantly lower in obese LPS group compared to lean LPS group at 90 min (10 [8-17] vs. 5 [2-9] ng/ml; p=0.04).</p></sec><sec id="Sec5"><title>Conclusions</title><p>In our model of endotoxic shock, obese pigs developed a more severe disseminated intravascular coagulation with a more serious procoagulant response.</p></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angstwurm</surname><given-names>MWA</given-names></name><etal/></person-group><source>Crit Care Med</source><year>2006</year><volume>34</volume><issue>2</issue><fpage>314</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000196832.27501.B2</pub-id><pub-id pub-id-type="pmid">16424708</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoppa-Vaucher</surname><given-names>S</given-names></name><etal/></person-group><source>Obes Silver Spring Md</source><year>2012</year><volume>20</volume><issue>8</issue><fpage>1662</fpage><lpage>1668</lpage><pub-id pub-id-type="doi">10.1038/oby.2012.85</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semeraro</surname><given-names>F</given-names></name><etal/></person-group><source>Thromb Haemost</source><year>2012</year><volume>108</volume><issue>2</issue><fpage>311</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1160/TH11-12-0864</pub-id><pub-id pub-id-type="pmid">22740053</pub-id></element-citation></ref></ref-list></back></article>